Literature DB >> 20605053

Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts.

Magdalena Ksiazkiewicz1, Eva Gottfried, Marina Kreutz, Matthias Mack, Ferdinand Hofstaedter, Leoni A Kunz-Schughart.   

Abstract

A considerable fraction of tumor-associated macrophages (TAM) is located in the fibroblast-rich stromal compartment of desmoplastic breast carcinoma. We analyzed the migratory activity of blood monocytes (MO), the precursor cells of TAM, into 3-D cultures of carcinoma cells and fibroblasts from breast tumor origin. MO migration into breast tumor spheroids was highly variable: Hs578T spheroids showed high MO infiltration rates, T47D cultures were intermediate, whereas BT549, BT474 and MCF-7 spheroids were poorly infiltrated. MO infiltration was also high in tumor-derived fibroblast spheroids; however, no MO subpopulation with specific infiltrative potential was identified by CD14/CD16 expression profile. The infiltration of MO could be inhibited by pre-exposure to pertussis and cholera toxins, but only pertussis toxin, which blocks G(i) protein function, entirely inhibited MO migration. The G(i) coupled CCL2 receptor CCR2A/2B was expressed on roughly all MO. Furthermore, highly infiltrated tumor-derived fibroblast and Hs578T spheroids secreted considerable amounts of CCL2. In line with this, the infiltration of MO into fibroblast spheroids was suppressed by either addition of recombinant CCL2 to disturb the CCL2 gradient or by pre-incubation of MO with a CCR2A/2B blocking antibody. MO infiltration of Hs578T spheroids, however, could not be inhibited by CCL2 receptor blockade. Our study clearly shows that the CCL2-CCR2A/2B pathway is crucial for the recruitment of blood MO into tumor fibroblastic areas, whereas additional factors may be relevant for the migration of MO into tumor cell sites. Copyright 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605053     DOI: 10.1016/j.imbio.2010.05.019

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  26 in total

1.  Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models.

Authors:  Kristie M Tevis; Ryan J Cecchi; Yolonda L Colson; Mark W Grinstaff
Journal:  Acta Biomater       Date:  2016-12-21       Impact factor: 8.947

2.  Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.

Authors:  David Bauer; Elizabeth Mazzio; Karam Fa Soliman; Equar Taka; Ebenezer Oriaku; Tracey Womble; Selina Darling-Reed
Journal:  Anticancer Res       Date:  2014-06       Impact factor: 2.480

Review 3.  Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.

Authors:  Yali Han; Yanwen Zhang; Tanghong Jia; Yuping Sun
Journal:  Tumour Biol       Date:  2015-02-15

4.  Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.

Authors:  Irene Brana; Antonio Calles; Patricia M LoRusso; Lorrin K Yee; Thomas A Puchalski; Shobha Seetharam; Bob Zhong; Carla J de Boer; Josep Tabernero; Emiliano Calvo
Journal:  Target Oncol       Date:  2014-06-15       Impact factor: 4.493

5.  Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.

Authors:  Didier Meseure; Kinan Drak Alsibai; Andre Nicolas
Journal:  Cancer Microenviron       Date:  2014-12-19

6.  Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.

Authors:  Anandi Sawant; Jonathan A Hensel; Diptiman Chanda; Brittney A Harris; Gene P Siegal; Akhil Maheshwari; Selvarangan Ponnazhagan
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

Review 7.  Immunity, inflammation, and cancer: an eternal fight between good and evil.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808

8.  Embedded Spheroids as Models of the Cancer Microenvironment.

Authors:  Kristie M Tevis; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Biosyst       Date:  2017-08-18

9.  Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth.

Authors:  Turid Hellevik; Ingvild Pettersen; Vivian Berg; Jack Bruun; Kristian Bartnes; Lill-Tove Busund; Anthony Chalmers; Roy Bremnes; Iñigo Martinez-Zubiaurre
Journal:  Transl Oncol       Date:  2013-02-01       Impact factor: 4.243

10.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.